We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inadequate Supervision of Trials Results in Investigator Warning
Inadequate Supervision of Trials Results in Investigator Warning
March 4, 2009
A Florida investigator did not properly supervise three clinical trials and failed to notify the IRB for two months that a subject had been hospitalized for a week in an intensive care unit for a bilateral pulmonary embolism, an FDA warning letter says.